Skip to main content

Table 1 Baseline demographics characteristics (safety sample)

From: A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting

N

Aripiprazole (n = 245)

Gender, n (% male)

100 (40.8)

Mean ± SD age, years

37.0 ± 10.9

Schizophrenia, n (%)

244 (99.6)

Social history:

 

Positive smoking history, n (%)

232 (94.7)

Alcohol or drug abuse within last 12 weeks, n (%)

0

CGI-S

3.84 ± 1.07

  1. CGI-S = Clinical Global Impression scale Severity of Illness score.